Get startedLog in
    Picture of Axsome Therapeutics logo

    AXSM — Axsome Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapFalling Star
    All News

    Axsome Therapeutics' ADHD drug meets main goal in late-stage study

    Picture of Axsome Therapeutics logoAxsome Therapeutics
    25/03/2025 11:09
    March 25 (Reuters) - Axsome Therapeutics AXSM.O said on Tuesday its experimental drug to treat attention deficit hyperactivity disorder (ADHD) met the main goal in a late-stage study.

 (Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)

 ((Mariam.ESunny@thomsonreuters.com;))

    Recent news on Axsome Therapeutics

    See all news